% | $
Quotes you view appear here for quick access.

Alnylam Pharmaceuticals, Inc. Message Board

you are viewing a single comment's thread.

view the rest of the posts
  • thirdmeinvestor thirdmeinvestor Mar 2, 2007 3:46 PM Flag

    PCSK9 revisited


    07:31 ALNY Alnylam Pharmaceuticals and ISIS working together to consolidate intellectual property in miRNA field - Rodman & Renshaw (18.01 )

    Rodman & Renshaw notes that ALNY and ISIS are working together to consolidate the intellectual property in the miRNA field. Firm syas the cos announced today that the United States Patent and Trademark Office has allowed claims in a patent application that covers microRNAs and therapeutic molecules that target these miRNAs. The U.S.P.T.O. issued a Notice of Allowance for patent application 10/490,955, which is derived from the Tuschl III patent series licensed co-exclusively to Alnylam and Isis for miRNA therapeutics on a world-wide basis. The Tuschl III patent series pertains to the discovery of over 120 novel mammalian miRNAs. The co expect final issuance of the patent within six months. Firm says ALNY expects to file two additional INDs from its development pipeline in 2007 (pandemic influenza and PCSK9 for hypercholesterolemia) and also intends to advance two or more new development programs.

71.56+0.76(+1.07%)Aug 29 4:00 PMEDT